儿童烟雾病的临床表现及神经影像学特征分析

李洁; 刘睿; 李柱一; 吴大方; 马喜娟; 苗建亭

PDF(1176 KB)

中国当代儿科杂志 ›› 2010, Vol. 12 ›› Issue (08) : 637-640.

论著·临床研究

儿童烟雾病的临床表现及神经影像学特征分析

李洁，刘睿，李柱一，吴大方，马喜娟，苗建亭

作者信息 +

Clinical manifestations and neuroimaging characteristics of children with moyamoya disease

LI Jie, LIU Rui, LI Zhu-Yi, WU Da-Fang, MA Xi-Juan, MIAO Jian-Ting

Author information +

文章历史 +

摘要

目的：研究儿童烟雾病(MMD)的临床及影像学特征。方法：回顾性分析l7例儿童MMD的临床资料，对其临床表现及神经影像学特征、治疗进行分析。结果：发病年龄在3~14岁，临床表现为反复发作一侧肢体无力、偏瘫、感觉障碍、头痛等。头颅CT和磁共振（MRI）主要表现为脑梗死，磁共振血管成像(MRA)及数字减影血管造影(DSA)检查显示颈内动脉虹吸部末端和大脑前或中动脉近端狭窄或闭塞,脑基底部异常血管网形成。结论：儿童MMD发病类型以脑缺血常见，表现为肢体无力或偏瘫、感觉障碍和头痛。DSA检查是确诊烟雾病的主要方法，如具备手术条件的，可及早行血管重建术。［中国当代儿科杂志，2010，12（8）：637-640］

Abstract

OBJECTIVE: To study the clinical manifestations and neuroimaging characteristics of pediatric moyamoya disease. METHODS: The clinical data of 17 children with moyamoya disease were retrospectively studied. RESULTS: The onset age was between 3 and 14 years. The main clinical manifestations included motor weakness of extremities or hemiplegia, sensory disturbance and headache. Cranial CT or/and MRI examinations predominately showed cerebral infarct. Magnetic resonance angiography (MRA) and digital subtraction angiography (DSA) showed stenosis or occlusion at the terminus of the siphon portions of internal carotid arteries and proximal portions of anterior or middle cerebral arteries, and abnormal vascular networks at the base of brain. CONCLUSIONS: Cerebral ischemia is main clinical manifestations in children with moyamoya disease, presenting motor weakness of extremities or hemiplegia, sensory disturbance and headache. DSA is essential to the diagnosis of the disease.［Chin J Contemp Pediatr, 2010, 12 (8):637-640］

导出引用

李洁, 刘睿, 李柱一, 吴大方, 马喜娟, 苗建亭. 儿童烟雾病的临床表现及神经影像学特征分析[J]. 中国当代儿科杂志. 2010, 12(08): 637-640

LI Jie, LIU Rui, LI Zhu-Yi, WU Da-Fang, MA Xi-Juan, MIAO Jian-Ting. Clinical manifestations and neuroimaging characteristics of children with moyamoya disease[J]. Chinese Journal of Contemporary Pediatrics. 2010, 12(08): 637-640

中图分类号： R725.4

参考文献

［1］Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain［J］. Arch Neurol, 1969, 20(3):288-299.
［2］陈诤, 毛颖, 周良辅. 烟雾病的研究进展［J］. 国外医学·脑血管疾病分册, 2004, 12 (10) :761-764.
［3］Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya’disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan［J］. Clin Neurol Neurosurg, 1997, 99(2): s238-240.
［4］Seol HJ, Wang KC, Kim SK, Hwang YS, Kim KJ, Cho BK. Familial occurrence of moyamoya disease: a clinical study［J］. Childs Nerv Syst, 2006, 22(9):1143-1148.
［5］Yanagawa Y, Sugiura T, Suzuki K, Okada Y. Moyamoya disease associated with positive findings for rheumatoid factor and myeloperoxidaseantineutrophil cytoplasmic antibody［J］. West Indian Med J, 2007, 56(3):282-284.
［6］陈赞, 菅风增, 王伊鹏, 何川, 凌锋. 烟雾病免疫相关基因研究［J］. 中国脑血管病杂志, 2005, 2(5): 198.
［7］Desai SS, Paulino AC, Mai WY, Teh BS. Radiation-induced moyamoya syndrome［J］. Int J Radiat Oncol Biol Phys, 2006, 65 (4): 1222-1227.
［8］Matsushima Y, Qian L, Aoyagiu M. Comparison of moyamoya disease in Japan and moyamoya disease (or syndrome)in the People's Republic of China ［J］. Clin Neuro Neurosurg, 1997, 99 (Suppl 2): S19-S22.
［9］李洁，刘睿，李柱一，苗建亭.儿童与成人烟雾病临床表现及影象学特征分析［J］. 西南国防医药, 2010, 20 (3): 233-236.
［10］Yamada I, Suzuki S, Matsushima Y. Moyamoya disease: comparison of assessment with MR angiography and MR imaging versus conventional angiography ［J］. Radiology, 1995, 196(1): 211-218.
［11］Kim SK, Seol HJ, Cho BK, Hwang YS, Lee DS, Wang KC. Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment［J］. Neurosurgery, 2004, 54 (4): 840-844.
［12］Ozgur BM, Aryan HE, Levy ML. Indirect revascularization for paediatric moyamoya disease: the EDAMS technique［J］. J Clin Neurosci, 2006, 13(1): 105-108.
［13］Isono M, Ishii K, Kamida T, Inoue R, Fujiki M, Kobayashi H. Long-term outcomes of pediatric moyamoya disease treated by encephalo-duro-arterio-synangiosis［J］. Pediatr Neurosurg, 2002, 36(1): 14-21.